BridgeMD
Compares treatment options for Diabetes During Pregnancy
Official title Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic Patients
ClinicalTrials.gov ID: NCT07554287
What this study is testing
- What it's testing
- The current study is a single-blind, parallel-group randomized controlled trial involving 108 participants with diabetes during pregnancy. The trial will compare leg ergometer with arm ergometer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only
You may be able to join if
- Female participants aged 18-35 years.
- Gestational age 14-28 weeks (second trimester).
- Singleton pregnancy (confirmed by obstetric record) only to avoid complications of multiple gestation.
- Include both primigravida and multigravida (i.e., first or subsequent pregnancy).
- Women with first time GDM in pregnancy.
You likely can't join if
- Previous Cesarean section or medically indicated bed rest.
- Known pre-existing diabetes mellitus (Type 1 or Type 2 prior to pregnancy).
- Known major obstetric complications (e.g., placenta previa, severe pre- eclampsia).
- Patients having multiple/twin/triplet pregnancies.
- Known major fetal anomaly.
- Anemic women with Hb \< 9 g/dL (excluded to prevent exercise intolerance).
See the full eligibility criteria
- Female participants aged 18-35 years.
- Gestational age 14-28 weeks (second trimester).
- Singleton pregnancy (confirmed by obstetric record) only to avoid complications of multiple gestation.
- Include both primigravida and multigravida (i.e., first or subsequent pregnancy).
- Women with first time GDM in pregnancy.
- Women with clinical diagnosis of gestational diabetes according to hospital/WHO criteria or hospital diagnostic test.
- Blood glucose levels: Random capillary glucose \< 200 mg/dL at screening (to exclude overt diabetes)
- Blood pressure:
- Systolic BP \< 140 mmHg and Diastolic BP \< 90 mmHg (no confirmed gestational hypertension).
- If BP ≥140/90 mmHg, confirm with repeat measurement 4 hours apart; exclude if persistent.
- Willingness to participate and provide written informed consent.
- Medically cleared by obstetrician to participate in moderate aerobic exercise.
- Previous Cesarean section or medically indicated bed rest.
- Known pre-existing diabetes mellitus (Type 1 or Type 2 prior to pregnancy).
- Known major obstetric complications (e.g., placenta previa, severe pre- eclampsia).
- Patients having multiple/twin/triplet pregnancies.
- Known major fetal anomaly.
- Anemic women with Hb \< 9 g/dL (excluded to prevent exercise intolerance).
- Uncontrolled cardiovascular disease, musculoskeletal, or medical contraindications to exercise.
- Psychiatric conditions severe enough to hinder informed consent.
- Any other medical condition that, in the opinion of the obstetrician, makes participation unsafe.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.